Explore 2025 biosimilar approval trends, regional bottlenecks, and why most applications fail despite rising global market demand.Read More

The U.S. Food and Drug Administration (FDA) sets the global gold standard for drug regulation.Read More

India isn’t just a pharma market. It’s the engine that powers global access to affordable medicine.Read More

AI is transforming the pharmaceutical industry in 2025—driving breakthroughs in drug discovery, optimizing manufacturing, and fixing broken supply chains.Read More

2025 is turning out to be one of the most pivotal years for pharmaceutical M&A activity in recent history.Read More

In June 2025, the government imposed anti-dumping duties on four chemicals—most of them sourced from China.Read More

As we move deeper into 2025, biosimilars are gaining unprecedented traction.Read More

When it comes to global demand, few active pharmaceutical ingredients rival Ibuprofen, a widely trusted, fast-acting NSAID used across hospitals, retail shelves, and emergency protocols.Read More

The global cosmetic industry valued at $450 billion in 2025 isn’t just expanding.Read More

The biotech and pharma industries are evolving at breakneck speed. But most professionals still lump them together—missing the nuances that define their risks, opportunities, and strategic decisions.Read More